Genomically Matched Cancer Therapies Only as Good as Supporting Evidence

(MedPage Today) — Patients with advanced/refractory cancers treated with genomically matched therapies had better overall survival only when treatments were supported by prospective studies, a large multicenter cohort study in Australia showed…